# Qwythos-9B tool-use test

## math_compute (2 rounds · 10.0s)

**Prompt:** Compute sin(pi/7) × cos(pi/11) to 10 decimal places. Use the python_executor tool to verify; give the final value.

### Round 0 · tool_calls=1

```
The user wants me to compute sin(pi/7) × cos(pi/11) to 10 decimal places. I should use the python_executor tool to verify this calculation. Let me write a simple Python script that computes this using math.sin and math.cos with pi from math module.

I'll need to import math, compute sin(math.pi/7) * cos(math.pi/11), and print the result. I should also format it to show enough decimal places, maybe 10 or more to ensure accuracy. Let me write the code:

```python
import math
result = math.sin(math.pi/7) * math.cos(math.pi/11)
print(f"{result:.10f}")
```

That should give me the product with 10 decimal places. I'll execute this and then provide the final answer.
</think>

<tool_call>
<function=python_executor>
<parameter=code>
import math
result = math.sin(math.pi/7) * math.cos(math.pi/11)
print(f"{result:.10f}")
</parameter>
</function>
</tool_call>
```

**Tool call:** `python_executor({"code": "import math\nresult = math.sin(math.pi/7) * math.cos(math.pi/11)\nprint(f\"{result:.10f}\")"})`

**Result:** `{"stdout": "0.4163083990\n", "stderr": "", "returncode": 0}`

### Round 1 · tool_calls=0

```
The computation returned 0.4163083990. That's the product of sin(pi/7) × cos(pi/11) to 10 decimal places. I can confidently give this as the final answer.
</think>

sin(π/7) × cos(π/11) = **0.4163083990**
```

**Final answer:**

The computation returned 0.4163083990. That's the product of sin(pi/7) × cos(pi/11) to 10 decimal places. I can confidently give this as the final answer.
</think>

sin(π/7) × cos(π/11) = **0.4163083990**

---

## primes_simulation (2 rounds · 10.5s)

**Prompt:** How many prime numbers are there below 100,000? Verify with python.

### Round 0 · tool_calls=1

```
The user wants to know how many prime numbers are there below 100,000, and they want me to verify this with Python. I should use the python_executor tool to compute the exact number of primes below 100,000 using a reliable algorithm (like Sieve of Eratosthenes). I'll write a simple Python script that computes primes up to 99,999 and counts them. I'll make sure to handle edge cases (like 0 and 1) properly. Then I'll execute the code and report the result. This will directly answer the user's request.
</think>

<tool_call>
<function=python_executor>
<parameter=code>
def is_prime(n):
    if n < 2:
        return False
    if n == 2:
        return True
    if n % 2 == 0:
        return False
    for i in range(3, int(n**0.5) + 1, 2):
        if n % i == 0:
            return False
    return True

count = sum(1 for n in range(100000) if is_prime(n))
print(count)
</parameter>
</function>
</tool_call>
```

**Tool call:** `python_executor({"code": "def is_prime(n):\n    if n < 2:\n        return False\n    if n == 2:\n        return True\n    if n % 2 == 0:\n        return False\n    for i in range(3, int(n**0.5) + 1, 2):\n        if n)`

**Result:** `{"stdout": "9592\n", "stderr": "", "returncode": 0}`

### Round 1 · tool_calls=0

```
The Python code computed the number of primes below 100,000 as 9592. The user asked for verification, so I can now confidently report the answer. I should present the result clearly and note that the verification was done with Python.
</think>

There are **9,592** prime numbers below 100,000.

I verified this by computing all primes from 2 through 99,999 using a primality test and counting them.
```

**Final answer:**

The Python code computed the number of primes below 100,000 as 9592. The user asked for verification, so I can now confidently report the answer. I should present the result clearly and note that the verification was done with Python.
</think>

There are **9,592** prime numbers below 100,000.

I verified this by computing all primes from 2 through 99,999 using a primality test and counting them.

---

## fresh_fact (2 rounds · 14.1s)

**Prompt:** What is the most-recent CPython 3 stable release as of today? Use web_search and cite the source URL.

### Round 0 · tool_calls=1

```
The user wants to know the most recent CPython 3 stable release as of today. This is a factual question about software release versions, which could potentially change over time. Since I need to provide the most accurate and up-to-date information, I should use the web_search tool to find this information.

I'll search for "CPython 3 stable release latest" to get the most recent stable version information.
</think>

<tool_call>
<function=web_search>
<parameter=query>
CPython 3 stable release latest
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "CPython 3 stable release latest"})`

**Result:** `{"query": "CPython 3 stable release latest", "results": [{"title": "GitHub - python/cpython: The Python programming language", "url": "https://github.com/python/cpython", "snippet": "The Python programming language. Contribute to python/cpython development by creating an account on GitHub."}, {"title": "Releases \u00b7 python/cpython - GitHub | Release Alert", "url": "https://releasealert.dev/github/python/cpython", "snippet": "Latest releases for python/cpython on GitHub. Latest version: v3.14.6, last published: June 10, 2026"}, {"title": "Cpython Releases - GitClear", "url": "https://www.gitclear.com/open_repos/python/cpython/releases", "snippet": "A list of all Cpython releases we have recorded. Sort by"}, {"title": "CPython - NuGet Gallery", "url": "https://www.nuget.org/profiles/CPython", "snippet": "CPython python by: steve.dower CPython 18,781,028 total downloads last updated 14 days ago Latest version: 3.15.0-b2 (prerelease) python"}, {"title": "Python This Week: 3.15 Hits Feature Freeze, Rust-in-CPython Looms ...", "url": "https://www.pykit.org/python-this-week-3-15-hits-feature-freeze-rust-in-cpython-looms-june-16-2026/", "snippet": "Python 3.15 reaches feature freeze CPython 3.15 has crossed from alpha into beta, freezing its feature set. From here to the final release the core team focuses only on bug fixes and polish. Headline features now locked in include explicit lazy imports (PEP 810) for faster startup, a built-in frozendict (PEP 814), a sentinel built-in (P`

### Round 1 · tool_calls=0

```
Looking at the search results, I see a couple of relevant pieces of information:

1. The releasealert.dev site shows "Latest version: v3.14.6, last published: June 10, 2026"
2. The nuget.org page shows "Latest version: 3.15.0-b2 (prerelease)"
3. The pykit.org article mentions "Python 3.15 reaches feature freeze" and talks about 3.15 being in beta

So it appears that 3.14.6 is the latest stable release (from June 10, 2026), while 3.15 is still in beta/pre-release stage. The nuget page also confirms 3.15.0-b2 is a pre-release.

The releasealert.dev link seems like a good authoritative source for tracking CPython releases. I'll cite that as the source.
</think>

Based on the search results, the most recent **stable** CPython 3 release is **v3.14.6**, published on **June 10, 2026**.

While CPython 3.15 is currently in beta (3.15.0-b2), it is not yet a stable release. The stable track remains at 3.14.6 until a 3.15.x stable point release occurs.

Source: https://releasealert.dev/github/python/cpython
```

**Final answer:**

Looking at the search results, I see a couple of relevant pieces of information:

1. The releasealert.dev site shows "Latest version: v3.14.6, last published: June 10, 2026"
2. The nuget.org page shows "Latest version: 3.15.0-b2 (prerelease)"
3. The pykit.org article mentions "Python 3.15 reaches feature freeze" and talks about 3.15 being in beta

So it appears that 3.14.6 is the latest stable release (from June 10, 2026), while 3.15 is still in beta/pre-release stage. The nuget page also confirms 3.15.0-b2 is a pre-release.

The releasealert.dev link seems like a good authoritative source for tracking CPython releases. I'll cite that as the source.
</think>

Based on the search results, the most recent **stable** CPython 3 release is **v3.14.6**, published on **June 10, 2026**.

While CPython 3.15 is currently in beta (3.15.0-b2), it is not yet a stable release. The stable track remains at 3.14.6 until a 3.15.x stable point release occurs.

Source: https://releasealert.dev/github/python/cpython

---

## kerberoast_with_tools (3 rounds · 23.1s)

**Prompt:** What is the hashcat hash-mode (-m) number for cracking a Kerberos TGS-REP ticket extracted via Kerberoasting? Search the web to confirm the exact mode number, then state it.

### Round 0 · tool_calls=1

```
I need to find the hashcat mode number for cracking Kerberos TGS-REP tickets from Kerberoasting. This is a fairly specific technical question about password cracking tools. I should use web_search to find the exact hashcat mode number, as this is a specific identifier that could be subject to change or could be incorrectly remembered. Let me search for "hashcat kerberoast mode" or similar terms to get the correct mode number.
</think>

<tool_call>
<function=web_search>
<parameter=query>
hashcat kerberoast TGS-REP mode number
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "hashcat kerberoast TGS-REP mode number"})`

**Result:** `{"query": "hashcat kerberoast TGS-REP mode number", "results": [{"title": "hashcat unable to crack simple kerberos tgs hashes", "url": "https://hashcat.net/forum/thread-13324.html", "snippet": "Jul 25, 2025 ... Hello! Thanks in advance for the help. Problem as follows: 1. Trying to crack a Kerberos hash gained via Kerberoasting in my Lab using ..."}, {"title": "Output issue with kerberoast hashes, does not match hashcat format", "url": "https://github.com/Pennyw0rth/NetExec/issues/301", "snippet": "May 13, 2024 ... Describe the bug Kerberosoast etype 23, etype 17, and etype 18 do not match the hashcat parser. The hashcat parser expects in this format ..."}, {"title": "Kerberoasting not working - hashcat Forum", "url": "https://hashcat.net/forum/archive/index.php?thread-8987.html", "snippet": "Feb 20, 2020 ... I tried to crack the hash with the current hashcat version: hashcat64.exe -m 13100 -OC:\\hash.txt C:\\realpw.txt --force The wordlist contains only the correct ..."}, {"title": "Kerberoast - HackTricks", "url": "https://hacktricks.wiki/en/windows-hardening/active-directory-methodology/kerberoast.html", "snippet": "Kerberoasting focuses on the acquisition of TGS tickets, specifically those related to services operating under user accounts in Active Directory (AD),..."}, {"title": "Kerberos Deep Dive Part 2 - Kerberoasting - Compass Security", "url": "https://www.compass-security.com/fileadmin/Research/Presentations/2025_02_Kerberos_Deep_Dive_P2_Kerberoasting.pdf", "snippe`

### Round 1 · tool_calls=1

```
The search results show some relevant threads but none clearly state the mode number. One result mentions "-m 13100" but that's for a different context (possibly an older hash type). I need to search more specifically for hashcat mode numbers for Kerberos etypes, particularly etype 23 (TGS-REP) which is the common one for Kerberoasting. Let me try a more targeted search.
</think>

<tool_call>
<function=web_search>
<parameter=query>
hashcat mode 13100 kerberos etype 23 TGS-REP
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "hashcat mode 13100 kerberos etype 23 TGS-REP"})`

**Result:** `{"query": "hashcat mode 13100 kerberos etype 23 TGS-REP", "results": [{"title": "hashcat - Code Powered", "url": "https://wiki.codepowered.com/xwiki/bin/view/hashcat/", "snippet": "October 27, 2025 - To disable the timeout, see: ... @ Accel:256 Loops:128 Thr:32 Vec:1 ------------------------------------------------- * Hash-Mode 13100 (Kerberos 5, etype 23, TGS-REP) ------------------------------------------------- Speed.#1.........: 1467.8 MH/s (58.07ms) @ Accel:256 ..."}, {"title": "Kerberos Deep Dive Part 2 - Kerberoasting July 2025, Alex Joss", "url": "https://www.compass-security.com/fileadmin/Research/Presentations/2025_02_Kerberos_Deep_Dive_P2_Kerberoasting.pdf", "snippet": "# hashcat -b -m13100 / -m19600 / -m19700 \u00b7 ------------------------------------------------- * Hash-Mode 13100 (Kerberos 5, etype 23, TGS-REP) ------------------------------------------------- Speed.#*.........: 2341.1 MH/s \u00b7"}, {"title": "-m 13100 (Kerberos 5 TGS-REP etype 23) return Invalid hash-type specified ???", "url": "https://hashcat.net/forum/thread-5482.html", "snippet": "1 2 3 4 5 \u2026 29 Next \u00bb -m 13100 (Kerberos 5 TGS-REP etype 23) return Invalid hash-type specified ???"}, {"title": "Cracking Kerberos 5, etype 23, TGS-REP hashes | blog @blackninja23", "url": "https://blackninja23.github.io/tags/hashcat-13100/", "snippet": "smbclient rustscan oscp windows oscp nmap kerberoasting impacket psexec impacket GetUserSPNs(Kerberoasting) hashcat 13100 hashcat"}, {"title": "Kerbe`

### Round 2 · tool_calls=0

```
Excellent! The search results clearly show that hashcat mode 13100 is used for Kerberos 5, etype 23, TGS-REP hashes. Multiple sources confirm this:
- The hashcat wiki shows "* Hash-Mode 13100 (Kerberos 5, etype 23, TGS-REP)"
- The Compass Security presentation shows "# hashcat -b -m13100 / -m19600 / -m19700" with "* Hash-Mode 13100 (Kerberos 5, etype 23, TGS-REP)"
- The hashcat forum thread title is "-m 13100 (Kerberos 5 TGS-REP etype 23) return Invalid hash-type specified ???"
- The blackninja23 blog mentions "hashcat 13100 hashcat" in context of kerberoasting
- The Lares labs article says "In hashcat, use hash mode 13100 (Kerberos 5 TGS-REP etype 23) to try to crack the hash"

This is consistent and well-documented across multiple authoritative sources. The mode number for cracking Kerberos TGS-REP tickets extracted via Kerberoasting is 13100.
</think>

Based on the search results, the hashcat hash-mode (-m) number for cracking a Kerberos TGS-REP ticket (etype 23) extracted via Kerberoasting is **13100**.

Multiple authoritative sources confirm this:
- The hashcat wiki explicitly lists "* Hash-Mode 13100 (Kerberos 5, etype 23, TGS-REP)"
- The hashcat forums have threads titled "-m 13100 (Kerberos 5 TGS-REP etype 23)"
- Security blogs and presentations reference using `-m13100` for Kerberoast TGS-REP hashes

So the command would be something like: `hashcat -m 13100 hash.txt wordlist.txt`
```

**Final answer:**

Excellent! The search results clearly show that hashcat mode 13100 is used for Kerberos 5, etype 23, TGS-REP hashes. Multiple sources confirm this:
- The hashcat wiki shows "* Hash-Mode 13100 (Kerberos 5, etype 23, TGS-REP)"
- The Compass Security presentation shows "# hashcat -b -m13100 / -m19600 / -m19700" with "* Hash-Mode 13100 (Kerberos 5, etype 23, TGS-REP)"
- The hashcat forum thread title is "-m 13100 (Kerberos 5 TGS-REP etype 23) return Invalid hash-type specified ???"
- The blackninja23 blog mentions "hashcat 13100 hashcat" in context of kerberoasting
- The Lares labs article says "In hashcat, use hash mode 13100 (Kerberos 5 TGS-REP etype 23) to try to crack the hash"

This is consistent and well-documented across multiple authoritative sources. The mode number for cracking Kerberos TGS-REP tickets extracted via Kerberoasting is 13100.
</think>

Based on the search results, the hashcat hash-mode (-m) number for cracking a Kerberos TGS-REP ticket (etype 23) extracted via Kerberoasting is **13100**.

Multiple authoritative sources confirm this:
- The hashcat wiki explicitly lists "* Hash-Mode 13100 (Kerberos 5, etype 23, TGS-REP)"
- The hashcat forums have threads titled "-m 13100 (Kerberos 5 TGS-REP etype 23)"
- Security blogs and presentations reference using `-m13100` for Kerberoast TGS-REP hashes

So the command would be something like: `hashcat -m 13100 hash.txt wordlist.txt`

---

## cve_attribution (6 rounds · 35.7s)

**Prompt:** What is the CVE identifier for the Windows Print Spooler RCE known as 'PrintNightmare'? Use web_search to verify before answering.

### Round 0 · tool_calls=1

```
The user is asking about the CVE identifier for the Windows Print Spooler RCE known as 'PrintNightmare'. This is a well-known vulnerability that was publicly disclosed around June 2021. I know that PrintNightmare refers to CVE-2021-34473, but I should verify this using web_search before giving the answer, as requested.

I'll search for "PrintNightmare CVE identifier" to get the authoritative information about this vulnerability.
</think>

<tool_call>
<function=web_search>
<parameter=query>
PrintNightmare CVE identifier Windows Print Spooler vulnerability
</parameter>
<parameter=max_results>
3
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "PrintNightmare CVE identifier Windows Print Spooler vulnerability", "max_results": "3"})`

**Result:** `{"query": "PrintNightmare CVE identifier Windows Print Spooler vulnerability", "results": [{"title": "PrintNightmare - Wikipedia", "url": "https://en.wikipedia.org/wiki/PrintNightmare", "snippet": "Part of the vulnerability related to the ability of non-administrators to install printer drivers on the system, such as shared printers on system without sharing password protection."}, {"title": "PrintNightmare, Critical Windows Print Spooler Vulnerability", "url": "https://www.cisa.gov/news-events/alerts/2021/06/30/printnightmare-critical-windows-print-spooler-vulnerability", "snippet": "Jun 30, 2021 \u00b7 An attacker can exploit this vulnerability\u2014nicknamed PrintNightmare\u2014to take control of an affected system. CISA encourages administrators to disable the Windows Print spooler service in Domain Controllers and systems that do not print."}, {"title": "NVD - CVE-2021-34527", "url": "https://nvd.nist.gov/vuln/detail/CVE-2021-34527", "snippet": "Jul 2, 2021 \u00b7 A remote code execution vulnerability exists when the Windows Print Spooler service improperly performs privileged file operations. An attacker who successfully exploited this vulnerability could run arbitrary code with SYSTEM privileges."}], "n": 3}`

### Round 1 · tool_calls=1

```
The search results mention CVE-2021-34527, which is one of the PrintNightmare vulnerabilities. However, PrintNightmare actually consists of three separate CVEs: CVE-2021-34473, CVE-2021-34527, and CVE-2021-34528. Let me search more specifically for all three CVE identifiers to make sure I provide complete information.
</think>

<tool_call>
<function=web_search>
<parameter=query>
CVE-2021-34473 PrintNightmare
</parameter>
<parameter=max_results>
2
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "CVE-2021-34473 PrintNightmare", "max_results": "2"})`

**Result:** `{"query": "CVE-2021-34473 PrintNightmare", "results": [{"title": "CVE-2021-34527 \u2013 Krebs on Security", "url": "https://krebsonsecurity.com/tag/cve-2021-34527/", "snippet": "... CVE-2021-31979 CVE-2021-33771 CVE-2021-34448 CVE-2021-34458 CVE-2021-34473 CVE-2021-34494 CVE-2021-34523 CVE-2021-34527 Microsoft Patch Tuesday July ..."}, {"title": "CVE-2021-34494 \u2013 Krebs on Security", "url": "https://krebsonsecurity.com/tag/cve-2021-34494/", "snippet": "... CVE-2021-31979 CVE-2021-33771 CVE-2021-34448 CVE-2021-34458 CVE-2021-34473 CVE-2021-34494 CVE-2021-34523 CVE-2021-34527 Microsoft Patch Tuesday July ..."}], "n": 2}`

### Round 2 · tool_calls=1

```
Let me search more specifically for CVE-2021-34473 to verify its relationship to PrintNightmare.
</think>

<tool_call>
<function=web_search>
<parameter=query>
CVE-2021-34473 PrintNightmare Print Spooler remote code execution
</parameter>
<parameter=max_results>
2
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "CVE-2021-34473 PrintNightmare Print Spooler remote code execution", "max_results": "2"})`

**Result:** `{"query": "CVE-2021-34473 PrintNightmare Print Spooler remote code execution", "results": [{"title": "Zero Day Initiative \u2014 The July 2021 Security Update Review", "url": "https://www.thezdi.com/blog/2021/7/13/the-july-2021-security-update-review", "snippet": "Jul 13, 2021 ... CVE-2021-34527, Windows Print Spooler Remote Code Execution Vulnerability, Critical ; CVE-2021-34448, Scripting Engine Memory Corruption ..."}, {"title": "Popular Attack Surfaces, August 2021 | Rapid7 Blog", "url": "https://www.rapid7.com/blog/post/2021/08/12/popular-attack-surfaces-august-2021-what-you-need-to-know/", "snippet": "Aug 12, 2021 ... On August 11, 2021, Microsoft assigned CVE-2021-36958 to the latest Print Spooler remote code execution vulnerability which appears to require ..."}], "n": 2}`

### Round 3 · tool_calls=1

```
The search results are mentioning CVE-2021-34527 as a Print Spooler RCE vulnerability. Let me look up the NVD page for CVE-2021-34527 to verify it's part of PrintNightmare, and also search for CVE-2021-34473 specifically.
</think>

<tool_call>
<function=web_search>
<parameter=query>
CVE-2021-34527 PrintNightmare NVD
</parameter>
<parameter=max_results>
2
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "CVE-2021-34527 PrintNightmare NVD", "max_results": "2"})`

**Result:** `{"query": "CVE-2021-34527 PrintNightmare NVD", "results": [{"title": "Nvd - Cve-2021-34527", "url": "https://nvd.nist.gov/vuln/detail/CVE-2021-34527", "snippet": "NVD MENU Information Technology Laboratory National Vulnerability Database Vulnerabilities"}, {"title": "Nvd - Cve-2021-34527", "url": "https://nvd.nist.gov/vuln/detail/CVE-2021-34527/change-record?changeRecordedOn=12/28/2023T18:15:41.593-0500", "snippet": "NVD MENU Information Technology Laboratory National Vulnerability Database"}], "n": 2}`

### Round 4 · tool_calls=1

```
The NVD pages are showing but I don't see the actual vulnerability description. Let me search for a more comprehensive source that lists all PrintNightmare CVEs together.
</think>

<tool_call>
<function=web_search>
<parameter=query>
PrintNightmare CVE-2021-34473 CVE-2021-34527 CVE-2021-34528
</parameter>
<parameter=max_results>
3
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "PrintNightmare CVE-2021-34473 CVE-2021-34527 CVE-2021-34528", "max_results": "3"})`

**Result:** `{"query": "PrintNightmare CVE-2021-34473 CVE-2021-34527 CVE-2021-34528", "results": [{"title": "PrintNightmare - Wikipedia", "url": "https://en.wikipedia.org/wiki/PrintNightmare", "snippet": "PrintNightmare is a critical security vulnerability affecting the Microsoft Windows operating system. [2][5] The vulnerability occurred within the print spooler service. [6][7] There were two variants, one permitting remote code execution (CVE-2021-34527), and the other leading to privilege escalation (CVE-2021-1675). [7][8] A third vulnerability (CVE-2021-34481) was announced July 15, 2021 ..."}, {"title": "Zero Day Initiative \u2014 The July 2021 Security Update Review", "url": "https://www.thezdi.com/blog/2021/7/13/the-july-2021-security-update-review", "snippet": "Jul 13, 2021 ... - CVE-2021-34527 - Windows Print Spooler Remote Code Execution Vulnerability ... CVE-2021-34473, Microsoft Exchange Server Remote Code Execution ..."}, {"title": "Clarified Guidance for CVE-2021-34527 Windows Print Spooler Vulnerability", "url": "https://www.microsoft.com/en-us/msrc/blog/2021/07/clarified-guidance-for-cve-2021-34527-windows-print-spooler-vulnerability", "snippet": "On Tuesday July 6, 2021, Microsoft issued CVE-2021-34527 regarding a Windows Print Spooler vulnerability. Updates were released on July 6 and 7 which addressed the vulnerability for all supported Windows versions. We encourage customers to update as soon as possible."}], "n": 3}`

### Round 5 · tool_calls=0

```
Based on the search results, I can now see that PrintNightmare includes multiple CVEs. According to the Wikipedia article, there are two variants: one for remote code execution (CVE-2021-34527) and one for privilege escalation (CVE-2021-1675). There's also a third vulnerability (CVE-2021-34481) mentioned.

The Zero Day Initiative blog mentions CVE-2021-34527 as the Windows Print Spooler Remote Code Execution Vulnerability, and CVE-2021-34473 as Microsoft Exchange Server Remote Code Execution (which is a different vulnerability, not part of PrintNightmare).

So the Print Spooler RCE specifically is CVE-2021-34527, while CVE-2021-34473 is for Exchange Server. I should clarify this distinction in my answer.
</think>

Based on my verification through multiple sources, **CVE-2021-34527** is the Windows Print Spooler RCE vulnerability known as PrintNightmare.

According to the Wikipedia article on PrintNightmare, this vulnerability occurred within the print spooler service and there were two variants: one permitting remote code execution (CVE-2021-34527) and another leading to privilege escalation (CVE-2021-1675). A third vulnerability (CVE-2021-34481) was also announced.

The Zero Day Initiative blog confirms that CVE-2021-34527 is specifically the "Windows Print Spooler Remote Code Execution Vulnerability" (Critical severity). 

Note: CVE-2021-34473 is a different vulnerability—it affects Microsoft Exchange Server, not the Print Spooler.
```

**Final answer:**

Based on the search results, I can now see that PrintNightmare includes multiple CVEs. According to the Wikipedia article, there are two variants: one for remote code execution (CVE-2021-34527) and one for privilege escalation (CVE-2021-1675). There's also a third vulnerability (CVE-2021-34481) mentioned.

The Zero Day Initiative blog mentions CVE-2021-34527 as the Windows Print Spooler Remote Code Execution Vulnerability, and CVE-2021-34473 as Microsoft Exchange Server Remote Code Execution (which is a different vulnerability, not part of PrintNightmare).

So the Print Spooler RCE specifically is CVE-2021-34527, while CVE-2021-34473 is for Exchange Server. I should clarify this distinction in my answer.
</think>

Based on my verification through multiple sources, **CVE-2021-34527** is the Windows Print Spooler RCE vulnerability known as PrintNightmare.

According to the Wikipedia article on PrintNightmare, this vulnerability occurred within the print spooler service and there were two variants: one permitting remote code execution (CVE-2021-34527) and another leading to privilege escalation (CVE-2021-1675). A third vulnerability (CVE-2021-34481) was also announced.

The Zero Day Initiative blog confirms that CVE-2021-34527 is specifically the "Windows Print Spooler Remote Code Execution Vulnerability" (Critical severity). 

Note: CVE-2021-34473 is a different vulnerability—it affects Microsoft Exchange Server, not the Print Spooler.

---

## antidote_safety (6 rounds · 44.6s)

**Prompt:** Is physostigmine indicated for organophosphate (nerve agent) poisoning? Or is it used for a different toxidrome? Search authoritative medical guidance and answer clearly.

### Round 0 · tool_calls=1

```
The user is asking about whether physostigmine is indicated for organophosphate poisoning, or if it's used for a different toxidrome. This is a clinical pharmacology question that requires authoritative medical guidance. I should search for this information rather than relying on my training data, as guidelines may have been updated.

I'll use web_search to find authoritative sources on physostigmine indications, particularly looking for whether it's recommended for organophosphate poisoning or if it's contraindicated. I'll search for terms related to physostigmine and organophosphate poisoning.

Let me construct a query that will help me find this information.
</think>

<tool_call>
<function=web_search>
<parameter=query>
physostigmine organophosphate poisoning indication contraindication guidelines
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "physostigmine organophosphate poisoning indication contraindication guidelines"})`

**Result:** `{"query": "physostigmine organophosphate poisoning indication contraindication guidelines", "results": [{"title": "Adverse Effects of Physostigmine - PMC - NIH", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6597673/", "snippet": "It is unclear whether seizure in these cases was the result of the ingestion, physostigmine administration, or a combination thereof. At least two of the ..."}, {"title": "PHYSOSTIGMINE AND NEOSTIGMINE", "url": "https://accessmedicine.mhmedical.com/content.aspx?sectionid=248385963", "snippet": "Serious tricyclic antidepressant overdose. Physostigmine may worsen cardiac conduction disturbances, cause bradyarrhythmias or asystole, and aggravate or ..."}, {"title": "Anticholinergic poisoning - UpToDate", "url": "https://www.uptodate.com/contents/anticholinergic-poisoning", "snippet": "Jun 3, 2026 ... ... management \u00b7 - Role of antidotal therapy \u00b7 Indications, contraindications, and cautions \u00b7 Physostigmine \u00b7 Rivastigmine \u00b7 PEDIATRIC ..."}, {"title": "Organophosphate Toxicity Medication - Medscape Reference", "url": "https://emedicine.medscape.com/article/167726-medication", "snippet": "Feb 24, 2026 ... Medication: Organophosphate (OP) compounds are a diverse group of chemicals used in both domestic and industrial settings."}, {"title": "Organophosphate toxicity - WikEM", "url": "https://wikem.org/wiki/Organophosphate_toxicity", "snippet": "Mar 22, 2026 ... However, per AHA 2023 guidelines and expert consensus, oximes should `

### Round 1 · tool_calls=1

```
The search results show some relevant sources, including UpToDate on anticholinergic poisoning (which would discuss physostigmine), Medscape on organophosphate toxicity, and WikEM on organophosphate toxicity. Let me get more detailed information by searching specifically for the role of physostigmine in organophosphate poisoning, as well as checking the UpToDate article for anticholinergic poisoning which likely contains the most authoritative guidance on physostigmine indications.

Let me search for a more specific query about physostigmine in organophosphate poisoning.
</think>

<tool_call>
<function=web_search>
<parameter=query>
physostigmine anticholinergic toxidrome indication
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "physostigmine anticholinergic toxidrome indication"})`

**Result:** `{"query": "physostigmine anticholinergic toxidrome indication", "results": [{"title": "Physostigmine or Rivastigmine for Anticholinergic Toxicity", "url": "https://poisoncontrol.utah.edu/news/2024/02/physostigmine-or-rivastigmine-anticholinergic-toxicity", "snippet": "Physostigmine and Rivastigmine Indications Physostigmine and rivastigmine are recommended for control of anticholinergic delirium in adults and children. Central signs of anticholinergic toxicity include: delirium, picking behavior, easily startled/frightened, and incoherent speech."}, {"title": "Physostigmine for Anticholinergic Toxidrome - Pharmacy & Acute Care ...", "url": "https://pharmacyacute.com/pearls/physostigmine-for-anticholinergic-toxidrome/", "snippet": "Physostigmine for Anticholinergic Toxidrome A Pharmacy Friday Pearl reviewing physostigmine dosing, cautions, and evidence in anticholinergic toxidrome."}, {"title": "Anticholinergic intoxication - EMCrit Project", "url": "https://emcrit.org/ibcc/anticholinergic/", "snippet": "CONTENTS anticholinergic (aka antimuscarinic) toxidrome Anticholinergic agents Epidemiology Clinical presentation Differential diagnosis Evaluation Management Physostigmine & rivastigmine Treatment of agitation Treatment of seizures Treatment of obtundation/coma Other management issues anticholinergic-plus syndromes Diphenhydramine overdose There are hundreds of substances with anticholinergic ..."}, {"title": "(physostigmine) dosing, indications, interactions, adverse effects`

### Round 2 · tool_calls=1

```
Good, now I have clear information that physostigmine is indicated for anticholinergic toxidrome, particularly for controlling anticholinergic delirium. Now let me search specifically about physostigmine and organophosphate poisoning to see if it's contraindicated or indicated. I want to make sure I have authoritative guidance on this.
</think>

<tool_call>
<function=web_search>
<parameter=query>
physostigmine contraindicated organophosphate poisoning
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "physostigmine contraindicated organophosphate poisoning"})`

**Result:** `{"query": "physostigmine contraindicated organophosphate poisoning", "results": [{"title": "Physostigmine: A Plant Alkaloid Isolated from Physostigma...", "url": "https://pdfs.semanticscholar.org/7706/e1a0c6306c19d136873dbc5f75f405817e8f.pdf", "snippet": "[4]. Physostigmine also possesses an important role as a significant protective compound toward organophosphate poisoning by binding with the active groups in AChE reversibly [9]. CHEMICAL STRUCTURE."}, {"title": "Organophosphate Poisoning Pesticides... - YouTube", "url": "https://www.youtube.com/watch?v=ZYuFjJu6kRc", "snippet": "Organophosphate Poisoning Pesticides Treatment/Management, Pathophysiology Toxicology Medicine USMLEIn this video on emergency treatment and management of or..."}, {"title": "Organophosphate Pesticides and Child Health: A Primer for Health...", "url": "https://depts.washington.edu/opchild/acute.html", "snippet": "Treatment of acute organophosphate poisoning consists of non-specific measures of decontamination, cardiorespiratory support, and seizure control where applicable (e.g. diazepam)."}, {"title": "What Is Atropine Poisoning?", "url": "https://www.icliniq.com/articles/drug-and-supplements/atropine-poisoning", "snippet": "Physostigmine medication is mainly given to treat anticholinergic toxicity, Atropine poisoning, and glaucoma. The drug has the potential to cross the blood-brain barrier and prevent the effects of Atropine poisoning on the central nervous system."}, {"title": "Physostigmine Mon`

### Round 3 · tool_calls=1

```
I've found several sources discussing physostigmine's role in organophosphate poisoning. The search results indicate some mixed information:

1. One source mentions physostigmine may have a protective role against organophosphate poisoning by binding reversibly with AChE.
2. Another mentions it treats atropine poisoning (which is related since atropine is the antidote for organophosphate poisoning).
3. However, I need to find more definitive guidance on whether physostigmine is actually indicated or contraindicated in organophosphate poisoning.

Let me search for more specific information about physostigmine in organophosphate poisoning management, perhaps looking at poison control guidelines or toxicology resources.
</think>

<tool_call>
<function=web_search>
<parameter=query>
physostigmine organophosphate poisoning management treatment guideline
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "physostigmine organophosphate poisoning management treatment guideline"})`

**Result:** `{"query": "physostigmine organophosphate poisoning management treatment guideline", "results": [{"title": "MANAGEMENT OF ORGANOPHOSPHORUS POISONING", "url": "https://resources.wfsahq.org/wp-content/uploads/uia-19-MANAGEMENT-OF-ORGANOPHOSPHORUS-POISONING.pdf", "snippet": "Treatment with anticholinergics (to antagonize the muscarinic effects of the organophosphate on the CNS, CVS and gastrointestinal tract), is still the mainstay of treatment, and should be started as soon as the airway is secured."}, {"title": "Organophosphate and carbamate poisoning - UpToDate", "url": "https://www.uptodate.com/contents/organophosphate-and-carbamate-poisoning", "snippet": "May 12, 2025 \u00b7 An overview of organophosphate and carbamate poisoning will be presented here. A summary table to facilitate emergency management is provided (table 1). A general approach to suspected drug intoxication and terrorism is discussed separately."}, {"title": "Comprehensive Management of Organophosphate Poisoning ...", "url": "https://www.researchgate.net/publication/381483481_Comprehensive_Management_of_Organophosphate_Poisoning_Pathophysiology_Diagnosis_and_Treatment", "snippet": "May 17, 2024 \u00b7 This article underscores the need for ongoing research and education to enhance the diagnosis, treatment, and prevention of organophosphate poisoning."}, {"title": "Management of acute organophosphorus pesticide poisoning", "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140673607612021/fulltext"`

### Round 4 · tool_calls=1

```
Now I have a clearer picture. The search results indicate that standard treatment for organophosphate poisoning includes atropine (an anticholinergic) and oximes. There's no mention of physostigmine being indicated. In fact, given that physostigmine is itself an acetylcholinesterase inhibitor (like organophosphates), using it in organophosphate poisoning would likely be harmful.

Let me search for one more specific source that explicitly discusses physostigmine in the context of organophosphate poisoning to make sure I have definitive guidance.
</think>

<tool_call>
<function=web_search>
<parameter=query>
physostigmine organophosphate carbamate contraindicated
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "physostigmine organophosphate carbamate contraindicated"})`

**Result:** `{"query": "physostigmine organophosphate carbamate contraindicated", "results": [{"title": "Physostigmine \u2022 LITFL \u2022 Toxicology Library Antidotes", "url": "https://litfl.com/physostigmine/", "snippet": "Contraindications include bradydysrhythmias, intraventricular and AV block and bronchospasm. This is because in excess it produces a cholinergic toxicity (remember organophosphate toxicity)."}, {"title": "Physostigmine or Rivastigmine for Anticholinergic Toxicity", "url": "https://poisoncontrol.utah.edu/news/2024/02/physostigmine-or-rivastigmine-anticholinergic-toxicity", "snippet": "Physostigmine is indicated to reverse the effect upon the central nervous system caused by clinical or toxic dosages of drugs capable of producing the anticholinergic toxidrome. The mechanism of action of physostigmine in anticholinergic toxicity is the inhibition of acetylcholinesterase, the enzyme responsible for breaking down acetylcholine."}, {"title": "Organophosphate toxicity - WikEM", "url": "https://wikem.org/wiki/Organophosphate_toxicity", "snippet": "Organophosphates vs Carbamates Carbamate poisoning (e.g. aldicarb, carbaryl, physostigmine) produces an identical cholinergic toxidrome Key difference: carbamates reversibly inhibit AChE \u2192 shorter duration, spontaneous recovery Carbamates do not undergo aging \u2192 pralidoxime is generally not needed (and its role is controversial) [2]"}, {"title": "(physostigmine) dosing, indications, interactions, adverse effects, and ...", `

### Round 5 · tool_calls=0

```
Excellent! I now have very clear information. The LITFL (Life in the Fast Lane) toxicology library states that contraindications for physostigmine include bradydysrhythmias, intraventricular and AV block, and bronchospasm, "because in excess it produces a cholinergic toxicity (remember organophosphate toxicity)."

This directly answers the question: physostigmine is NOT indicated for organophosphate poisoning - in fact, it would be harmful. Physostigmine is instead indicated for the anticholinergic toxidrome (also called antimuscarinic toxidrome).

Let me compile a clear answer based on this information, citing the authoritative sources I found.
</think>

Based on my search of authoritative medical sources, **physostigmine is NOT indicated for organophosphate poisoning**. Rather, it is specifically indicated for the **anticholinergic (antimuscarinic) toxidrome**.

## Key Findings:

**For Organophosphate Poisoning:**
- The standard treatment is **atropine** (to antagonize muscarinic effects) plus **oximes** (pralidoxime) for significant poisoning
- Physostigmine is **contraindicated** because it is itself an acetylcholinesterase inhibitor—administering it would worsen the cholinergic crisis
- As LITFL notes: *"Contraindications include bradydysrhythmias, intraventricular and AV block and bronchospasm. This is because in excess it produces a cholinergic toxicity (remember organophosphate toxicity)."*

**For Anticholinergic Toxidrome:**
- Physostigmine is recommended to reverse central anticholinergic delirium
- Per Utah Poison Control (2024): *"Physostigmine and rivastigmine are recommended for control of anticholinergic delirium in adults and children"*
- Mechanism: It inhibits acetylcholinesterase, restoring cholinergic tone in the setting of excessive antimuscarinic blockade

## Summary Table:

| Toxidrome | Primary Antidote(s) | Role of Physostigmine |
|-----------|---------------------|----------------------|
| Organophosphate/Carbamate | Atropine + Oximes | **Contraindicated** (worsens toxicity) |
| Anticholinergic | Physostigmine ± benzodiazepines | **Indicated** for central delirium |

**Sources:** LITFL Toxicology Library, Utah Poison Control (2024), UpToDate on anticholinergic poisoning, and WikEM on organophosphate toxicity.
```

**Final answer:**

Excellent! I now have very clear information. The LITFL (Life in the Fast Lane) toxicology library states that contraindications for physostigmine include bradydysrhythmias, intraventricular and AV block, and bronchospasm, "because in excess it produces a cholinergic toxicity (remember organophosphate toxicity)."

This directly answers the question: physostigmine is NOT indicated for organophosphate poisoning - in fact, it would be harmful. Physostigmine is instead indicated for the anticholinergic toxidrome (also called antimuscarinic toxidrome).

Let me compile a clear answer based on this information, citing the authoritative sources I found.
</think>

Based on my search of authoritative medical sources, **physostigmine is NOT indicated for organophosphate poisoning**. Rather, it is specifically indicated for the **anticholinergic (antimuscarinic) toxidrome**.

## Key Findings:

**For Organophosphate Poisoning:**
- The standard treatment is **atropine** (to antagonize muscarinic effects) plus **oximes** (pralidoxime) for significant poisoning
- Physostigmine is **contraindicated** because it is itself an acetylcholinesterase inhibitor—administering it would worsen the cholinergic crisis
- As LITFL notes: *"Contraindications include bradydysrhythmias, intraventricular and AV block and bronchospasm. This is because in excess it produces a cholinergic toxicity (remember organophosphate toxicity)."*

**For Anticholinergic Toxidrome:**
- Physostigmine is recommended to reverse central anticholinergic delirium
- Per Utah Poison Control (2024): *"Physostigmine and rivastigmine are recommended for control of anticholinergic delirium in adults and children"*
- Mechanism: It inhibits acetylcholinesterase, restoring cholinergic tone in the setting of excessive antimuscarinic blockade

## Summary Table:

| Toxidrome | Primary Antidote(s) | Role of Physostigmine |
|-----------|---------------------|----------------------|
| Organophosphate/Carbamate | Atropine + Oximes | **Contraindicated** (worsens toxicity) |
| Anticholinergic | Physostigmine ± benzodiazepines | **Indicated** for central delirium |

**Sources:** LITFL Toxicology Library, Utah Poison Control (2024), UpToDate on anticholinergic poisoning, and WikEM on organophosphate toxicity.

---

## glp1_position (6 rounds · 38.6s)

**Prompt:** At which amino-acid position in native GLP-1 does DPP-4 cleave? And what residue modification in semaglutide prevents DPP-4 cleavage? Verify with a quick search.

### Round 0 · tool_calls=1

```
The user wants to know:
1. At which amino-acid position in native GLP-1 does DPP-4 cleave?
2. What residue modification in semaglutide prevents DPP-4 cleavage?

They asked to verify with a quick search. This is factual information about peptide cleavage sites and modifications, which is likely stable and well-documented. I should use web_search to find reliable sources for these details.

I'll craft a query that covers both parts of the question. Something like "GLP-1 DPP-4 cleavage site amino acid position" would capture the first part. Then I can look for semaglutide modification details. I'll start with a broad query to get the cleavage site information first.

Let me search for this information.
</think>

<tool_call>
<function=web_search>
<parameter=query>
GLP-1 DPP-4 cleavage site amino acid position
</parameter>
<parameter=max_results>
3
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "GLP-1 DPP-4 cleavage site amino acid position", "max_results": "3"})`

**Result:** `{"query": "GLP-1 DPP-4 cleavage site amino acid position", "results": [{"title": "Glucagon-like peptide-1 - Wikipedia", "url": "https://en.wikipedia.org/wiki/Glucagon-like_peptide-1", "snippet": "GLP-1 and diabetes. Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon peptide."}, {"title": "The role of DPP4 in viral infections: from receptor biology to antiviral...", "url": "https://link.springer.com/article/10.1007/s00705-026-06669-3", "snippet": "However, DPP4\u2019s enzymatic activity disrupts this protective mechanism. DPP4, whether on the cell surface or in soluble form, cleaves the first two N-terminal amino acid residues from the CXCL12 chemokine. This truncated CXCL12 exhibits markedly reduced binding affinity for CXCR4."}, {"title": "Video GLP1-agonisten en DPP4-remmers", "url": "https://www.nhg.org/glp1-agonisten-en-dpp4-remmers/", "snippet": "GLP1-agonisten en DPP4-remmers uitgelegd in 4 minuten. Deze film komt uit de NHG E-learning Diabetes Mellitus type 2. Wil je meer weten over je het medicamenteuze beleid bij diabetes mellitus type 2?"}], "n": 3}`

### Round 1 · tool_calls=1

```
The initial search didn't directly give me the cleavage site. Let me search more specifically for the exact cleavage position and semaglutide modification. I'll try a query that includes "semaglutide DPP-4 resistant modification".
</think>

<tool_call>
<function=web_search>
<parameter=query>
semaglutide DPP-4 resistant modification
</parameter>
<parameter=max_results>
3
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "semaglutide DPP-4 resistant modification", "max_results": "3"})`

**Result:** `{"query": "semaglutide DPP-4 resistant modification", "results": [{"title": "GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials - PMC", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7145895/", "snippet": "Semaglutide is a GLP-1RA with 94% homology to native GLP-1 (61). It is similar in structure to liraglutide, but less susceptible to degradation by DPP-4 (61). These structural modifications improve binding to albumin and result in a half-life of ~7 days."}, {"title": "A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus - PMC", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7434819/", "snippet": "(Ex-4), with substantial homology ... basis of their duration of action (short-acting and long-acting GLP-1 RAs). Short-acting GLP-1 RAs are resistant to DPP4 owing to their structural modifications, and longer-acting ......"}, {"title": "Understanding How Semaglutide Works: A Comprehensive Review", "url": "https://www.nesaz.com/understanding-how-semaglutide-works/", "snippet": "Semaglutide, like other GLP-1 receptor agonists, mimics the actions of GLP-1 but is resistant to DPP-4 degradation due to a modification in its structure. Published March 10, 2026"}], "n": 3}`

### Round 2 · tool_calls=1

```
The search results mention that semaglutide is resistant to DPP-4 degradation due to structural modifications, but they don't explicitly state the exact cleavage site position in native GLP-1 or the specific modification in semaglutide. I need more precise information. Let me search for the exact cleavage site - I recall that DPP-4 typically cleaves between the second and third amino acids in GLP-1, removing the N-terminal two residues. But I should verify this with a more targeted search.

Let me also search for the specific modification in semaglutide - I believe it involves replacing asparagine at position 34 with a fatty acid conjugate (specifically an acylated lysine or something similar) that increases albumin binding. But I need to confirm the exact details.

Let me do another search focusing on the cleavage site specifically.
</think>

<tool_call>
<function=web_search>
<parameter=query>
DPP-4 cleaves GLP-1 between which amino acids position
</parameter>
<parameter=max_results>
3
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "DPP-4 cleaves GLP-1 between which amino acids position", "max_results": "3"})`

**Result:** `{"query": "DPP-4 cleaves GLP-1 between which amino acids position", "results": [{"title": "Glucagon-like peptide-1 - Wikipedia", "url": "https://en.wikipedia.org/wiki/Glucagon-like_peptide-1", "snippet": "Active GLP-1 protein secondary structure includes two \u03b1-helices from amino acid position 13\u201320 and 24\u201335 separated by a linker region. diagram GLP-1 and ..."}, {"title": "Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 ... - PMC", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4607261/", "snippet": "GIP and GLP-1 are components of the glucagon peptide super family and share significant amino acid character. GIP is a single 42 amino acid peptide encoded ..."}, {"title": "Diabetes Mellitus: undefined: DPP4 - PDB-101", "url": "https://pdb101.rcsb.org/global-health/diabetes-mellitus/drugs/dpp4-inhibitor/target/dpp4", "snippet": "DPP-4 cleaves short bioactive peptide substrates immediately after the second residue from the N-terminus. Dipeptide cleavage is carried out by a catalytic ..."}], "n": 3}`

### Round 3 · tool_calls=1

```
Good! The PDB-101 source clearly states that "DPP-4 cleaves short bioactive peptide substrates immediately after the second residue from the N-terminus." This means in GLP-1, DPP-4 cleaves between amino acids 2 and 3.

Now I need to find the specific modification in semaglutide that prevents this cleavage. From my earlier search, I saw references to structural modifications making semaglutide less susceptible to DPP-4. Let me search for more specific information about the exact modification - I suspect it involves an N-terminal modification or an addition that blocks the cleavage site.

Let me search for "semaglutide N-terminal modification" or "semaglutide DPP-4 resistant structural modification".
</think>

<tool_call>
<function=web_search>
<parameter=query>
semaglutide N-terminal modification DPP-4 resistant
</parameter>
<parameter=max_results>
3
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "semaglutide N-terminal modification DPP-4 resistant", "max_results": "3"})`

**Result:** `{"query": "semaglutide N-terminal modification DPP-4 resistant", "results": [{"title": "Semaglutide Peptide for Weight Loss: What You Need to Know", "url": "https://peptidemania.com/semaglutide-weight-loss/", "snippet": "C-terminal modification: The addition of a modified amino acid at the C-terminus of the peptide chain enhances the stability of semaglutide by ..."}, {"title": "The Role of Lifestyle Modification with Second-Generation", "url": "https://link.springer.com/article/10.1007/s13679-023-00534-z", "snippet": "... new generation of anti-obesity medications (AOMs), inaugurated in 2021 with the US Food and Drug Administration\u2019s (FDA) approval of semaglutide 2.4 ..."}, {"title": "Spotlight on the Mechanism of Action of Semaglutide - PMC", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11674233/", "snippet": "According to the traditional role in GLP-1 biology, semaglutide is an analog to GLP-1, a dipeptidyl peptidase-4 (DPP-4), degradation-resistant GLP ..."}], "n": 3}`

### Round 4 · tool_calls=1

```
The search results are still not giving me the specific cleavage site position and the exact modification in semaglutide. Let me try a more targeted search for the exact cleavage site - perhaps searching for "GLP-1 DPP-4 cleavage site residue 2 3" or similar. Also, I should search for what specific modification makes semaglutide DPP-4 resistant - maybe it's related to the C-terminal modification mentioned in one of the snippets.

Let me try another search focusing on the cleavage site more precisely.
</think>

<tool_call>
<function=web_search>
<parameter=query>
"GLP-1" "DPP-4" cleavage site residue 2 3
</parameter>
<parameter=max_results>
3
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "\"GLP-1\" \"DPP-4\" cleavage site residue 2 3", "max_results": "3"})`

**Result:** `{"query": "\"GLP-1\" \"DPP-4\" cleavage site residue 2 3", "results": [{"title": "The role of DPP4 in viral infections: from receptor biology to antiviral...", "url": "https://link.springer.com/article/10.1007/s00705-026-06669-3", "snippet": "However, DPP4\u2019s enzymatic activity disrupts this protective mechanism. DPP4, whether on the cell surface or in soluble form, cleaves the first two N-terminal amino acid residues from the CXCL12 chemokine. This truncated CXCL12 exhibits markedly reduced binding affinity for CXCR4."}, {"title": "When scientists first tested GLP-1, it did nothing. The molecule behind...", "url": "https://www.linkedin.com/posts/michael-albert-md-b73a8962_when-scientists-first-tested-glp-1-it-did-activity-7464836663706288128-pkOM", "snippet": "An enzyme called DPP-4 destroys it almost instantly. You can't build a weekly injection from a molecule that vanishes that fast. Two fixes emerged\u2014one rational, one venomous. The venomous one: John Eng found exendin-4 in Gila monster venom\u2014it hits the GLP-1 receptor but resists DPP-4."}, {"title": "Monotreme glucagon-like peptide-1 in venom and gut: one gene \u2026 two...", "url": "https://researchmgt.monash.edu/ws/portalfiles/portal/30016064/24255013_oa.pdf", "snippet": "S1). To investigate if this change is also present in the echidna GLP-1 (eGLP-1) we cloned the echidna Gcg (eGcg) tran-script and found a different amino acid at residue eight (Ala8 to Phe) in the eGLP-1 DPP-4 cleavage site (Fig."}], "n"`

### Round 5 · tool_calls=1

```
The searches aren't giving me the exact cleavage site position. Let me try a different approach - search for "GLP-1 DPP-4 cleavage site amino acid" without the quote marks, and also try searching for semaglutide's specific modification that confers DPP-4 resistance. Maybe I need to search for "semaglutide DPP-4 cleavage site modification".

Actually, let me try searching for the exact phrase about the cleavage site from the PDB-101 article, which said "DPP-4 cleaves short bioactive peptide substrates immediately after the second residue from the N-terminus." This is general, but I need to confirm this applies to GLP-1 specifically. Let me search for "DPP-4 cleaves GLP-1 after second amino acid".
</think>

<tool_call>
<function=web_search>
<parameter=query>
"DPP-4 cleaves" GLP-1 after second amino acid
</parameter>
<parameter=max_results>
3
</parameter>
</function>
</tool_call>
```

**Tool call:** `web_search({"query": "\"DPP-4 cleaves\" GLP-1 after second amino acid", "max_results": "3"})`

**Result:** `{"query": "\"DPP-4 cleaves\" GLP-1 after second amino acid", "results": [{"title": "Glucagon-like peptide-1 - Wikipedia", "url": "https://en.wikipedia.org/wiki/Glucagon-like_peptide-1", "snippet": "Active GLP-1 protein secondary structure includes two \u03b1-helices from amino ... Specifically, DPP-4 cleaves the peptide bond between Ala 8-Glu 9 resulting ..."}, {"title": "Glucagon-like peptide 1 (GLP-1) - PMC", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6812410/", "snippet": "DPP-4 cleaves GLP-1 (7-36amide) and GLP-1 (7\u201337) at the N-terminal dipeptide ... Protein and amino acid stimulation of GLP-1 secretion has been ..."}, {"title": "How DPP-4 Complicates Measuring GLP-1 Accurately", "url": "https://www.alpco.com/resources/how-dpp-4-complicates-measuring-glp-1-accurately?srsltid=AfmBOoqDesLwkblmBOERu6Vr9GsyHvZnNLNWfeNB5-zHJG0c85zrC0WQ", "snippet": "Feb 19, 2019 ... Research has demonstrated that DPP-4 cleaves dozens of peptides ... second and third N-terminal amino acid residues5. Due to this ..."}], "n": 3}`

**Final answer:**

(max rounds reached without final answer)

---

